Completed NA INTERVENTIONAL 2-arm NCT01838109

Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery

Multicenter, Prospective Randomized Controlled Trial Evaluating Postoperative Oral Nutritional Supplementation for the Patients Who Received Major Gastrointestinal Surgery

Sponsor: JW Pharmaceutical

Conditions Biliary Cancer Colon Cancer Duodenal Cancer Gastric Cancer Inflammatory Bowel Diseases Pancreatic Cancer Peptic Ulcer

Interventions oral nutritional supplement

Updated 6 times since 2017 Last updated: May 25, 2015 Started: Apr 30, 2013 Primary completion: Apr 30, 2014 Completion: Apr 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Biliary Cancer and Colon Cancer and is currently completed. JW Pharmaceutical leads this study, which shows 6 recorded versions since 2013 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Apr 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

JW Pharmaceutical
Seoul National University Hospital

Data source: Seoul National University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea